Global Antimicrobial Susceptibility Testing Market

Antimicrobial Susceptibility Testing Market Size, Share, Growth Analysis, By Test type(Phenotypic testing, genotypic testing, and rapid testing), By End user(Hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies), By Product type(Instruments, reagents and kits, and software and services), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2120 | Region: Global | Published Date: April, 2024
Pages: 219 |Tables: 90 |Figures: 76

Antimicrobial Susceptibility Testing Market Insights

Global Antimicrobial Susceptibility Testing Market size was valued at USD 3.79 billion in 2023 and is poised to grow from USD 3.98 billion in 2024 to USD 5.69 billion by 2031, at a CAGR of 5.2% during the forecast period (2024-2031).

Global Antimicrobial Susceptibility Testing (AST) Market is witnessing substantial growth, driven by the increasing prevalence of antimicrobial resistance and the need for effective treatment strategies. Antimicrobial susceptibility testing plays a crucial role in guiding clinicians to select appropriate antimicrobial therapies for patients, ensuring optimal treatment outcomes, and combating the rise of drug-resistant pathogens. The purpose of the market is to provide accurate and timely information on the susceptibility of microorganisms to various antibiotics. AST helps healthcare professionals make informed decisions regarding antibiotic selection, dosage, and treatment duration, aiding in the effective management of infectious diseases. By identifying the most effective antibiotics, AST enables personalized treatment plans, minimizes the risk of treatment failure, and contributes to antimicrobial stewardship efforts. Several key drivers are fueling the growth of the antimicrobial susceptibility testing market. The escalating burden of antimicrobial resistance, resulting in increased morbidity, mortality, and healthcare costs, drives the demand for AST. Additionally, the rise in infectious disease outbreaks, hospital-acquired infections, and the growing awareness about the need for targeted therapies fuel market expansion. The advent of rapid AST methods, automation, and the integration of molecular diagnostics into AST systems are further driving the market growth.

However, limited accessibility to advanced AST methods, particularly in resource-constrained settings, and the high cost associated with implementing sophisticated testing technologies may hinder the market growth. Moreover, the complexity of interpreting test results, challenges in standardizing testing methods, and the time-consuming nature of traditional AST methods pose challenges to market adoption. Key trends in the antimicrobial susceptibility testing market include the development of rapid and accurate AST systems, the integration of artificial intelligence (AI) and machine learning algorithms for data analysis, and the increasing focus on multiplex testing to detect multiple drug resistance patterns simultaneously. The market also presents significant opportunities for growth and innovation. The increasing demand for point-of-care testing, the adoption of automated AST systems in laboratories, and the growing need for personalized medicine in infectious disease management offer attractive prospects. Furthermore, collaborations between diagnostic companies, research institutions, and healthcare organizations can drive advancements in AST technologies and expand market reach.

US Antimicrobial Susceptibility Testing Market is poised to grow at sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 3.60 Billion

Largest Segment

Phenotypic Testing

Fastest Growth

Rapid Testing

Growth Rate

5.20% CAGR

Global Antimicrobial Susceptibility Testing Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Antimicrobial Susceptibility Testing Market Segmental Analysis

Global Antimicrobial Susceptibility Testing Market is segmented on the basis of test type, end user, product type, and region. By test type, the market is segmented into phenotypic testing, genotypic testing, and rapid testing. By end user, the market is segmented into hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies. By product type, the market is segmented into Instruments, reagents and kits, and software and services. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Antimicrobial Susceptibility Testing Market Analysis By Test Type

Phenotypic testing holds the largest market share due to its well-established and widely adopted methodologies. This type of testing involves observing the growth of microorganisms in the presence of different antibiotics and analyzing their response to determine their susceptibility or resistance. Phenotypic testing provides valuable information about the actual behavior of microorganisms, allowing clinicians to select the most effective antibiotics for treatment. Its robustness, reliability, and compatibility with various sample types contribute to its dominance in the market.

On the other hand, rapid testing is the fastest-growing segment in the antimicrobial susceptibility testing market. Rapid testing methods leverage advanced technologies, such as molecular diagnostics, to provide quick and accurate results, often within hours. These methods detect specific genetic markers or resistance genes in microorganisms, enabling rapid identification of resistance patterns. The ability to deliver timely results aids in the prompt initiation of targeted antibiotic therapy, leading to improved patient outcomes. The growing demand for faster turnaround times, the need to combat emerging drug resistance, and the increasing availability of advanced molecular diagnostic platforms drive the rapid testing segment's growth.

Antimicrobial Susceptibility Testing Market Analysis By Product Type

The instruments segment holds the largest market share due to its critical role in conducting accurate and efficient AST. These instruments include automated testing systems, broth microdilution systems, disk diffusion systems, and molecular diagnostic platforms. They provide reliable results, enable high-throughput testing, and offer enhanced workflow efficiency for laboratories and healthcare facilities. The increasing demand for rapid and accurate AST methods drives the adoption of advanced instruments, making it the dominant segment in the market.

The software and services segment is experiencing rapid growth in the AST market. With the rise of digitalization and the integration of informatics solutions in healthcare, software and services play a vital role in data management, result interpretation, and decision support. AST software facilitates the analysis of susceptibility data, assists in generating comprehensive reports, and helps healthcare professionals make informed treatment decisions. Additionally, services such as training, technical support, and maintenance contribute to the growth of this segment. The increasing focus on improving laboratory efficiency, data integration, and interoperability drives the adoption of software and services in the AST market.

Global Antimicrobial Susceptibility Testing Market By Test Type, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Antimicrobial Susceptibility Testing Market Regional Insights

North America dominated the global AST market, accounting for a substantial market share. The region's dominance can be attributed to several factors, including advanced healthcare infrastructure, well-established laboratory networks, and a strong focus on research and development activities. North America is home to prominent market players, such as bioMérieux, Thermo Fisher Scientific, and BD, which contribute to the region's market leadership. Additionally, the high prevalence of antimicrobial resistance and the proactive measures taken by healthcare organizations to address the issue drive the adoption of AST technologies in the region. With supportive government initiatives, strong investments in healthcare, and a growing emphasis on patient safety, North America holds a significant market share in the global AST market.

The Asia Pacific (APAC) region is the fastest growing region in the global AST market. APAC presents immense growth opportunities driven by factors such as the large patient population, rising incidence of infectious diseases, and increasing awareness about antimicrobial resistance. Countries like China and India, with their expanding healthcare infrastructure and significant investments in diagnostic laboratories, are witnessing a surge in demand for AST solutions. For instance, in India, the Indian Council of Medical Research (ICMR) has implemented a national antimicrobial resistance surveillance network, fueling the adoption of AST technologies. Moreover, the increasing focus on improving healthcare access, strengthening laboratory capabilities, and enhancing diagnostic accuracy contributes to the rapid growth of the AST market in the Asia Pacific region.

Global Antimicrobial Susceptibility Testing Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Antimicrobial Susceptibility Testing Market Dynamics

Antimicrobial Susceptibility Testing Market Drivers

Increasing prevalence of antimicrobial resistance

  • The rise in antimicrobial resistance is a significant driver for the AST market. The emergence of drug-resistant pathogens poses a severe threat to public health globally. For instance, the increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections has created a dire need for accurate AST to guide clinicians in selecting appropriate antibiotics for treatment.

Antimicrobial Susceptibility Testing Market Restraints

Limited accessibility to advanced AST methods

  • In resource-constrained settings, there may be limited access to sophisticated AST technologies, hindering market growth. For instance, low-income countries may face challenges in implementing automated AST systems due to their high costs and the need for trained personnel.

Request Free Customization of this report to help us to meet your business objectives.

Antimicrobial Susceptibility Testing Market Competitive Landscape

Global Antimicrobial Susceptibility Testing (AST) Market features a competitive landscape with several prominent players vying for market share. Key companies operating in the market are actively engaged in research and development activities to introduce advanced AST systems and technologies. Strategic collaborations, partnerships, and acquisitions are common strategies employed by these players to expand their product portfolio and strengthen their market presence. The market is characterized by intense competition, with a focus on innovation, cost-effectiveness, and accuracy of AST solutions. The presence of established players with strong distribution networks and brand recognition presents barriers to entry for new entrants.

Antimicrobial Susceptibility Testing Market Top Player’s Company Profile

  • Danaher Corporation (US)
  • Becton, Dickinson and Company (US)
  • Roche Diagnostics (Switzerland)
  • Abbott Laboratories (US)
  • Bruker Corporation (US)
  • Merck KGaA (Germany)
  • Agilent Technologies, Inc. (US)
  • ConvaTec Group plc (UK)
  • Cepheid (US)
  • HiMedia Laboratories Pvt. Ltd. (India)
  • Liofilchem s.r.l. (Italy)
  • Accelerate Diagnostics, Inc. (US)
  • Creative Diagnostics (US)
  • Bio-Rad Laboratories (US)
  • Synbiosis (UK)
  • ELITechGroup (France)
  • QIAGEN N.V. (Germany)

Antimicrobial Susceptibility Testing Market Recent Developments

  • In January 2023, bioMérieux unveiled its latest automated instrument called MAESTRIA. This innovative instrument is designed to streamline and automate various laboratory processes, offering enhanced efficiency and accuracy in diagnostics and testing procedures. 

  • In 2024, a novel method utilizing real-time polymerase chain reaction (PCR) has been developed for rapid antibiotic susceptibility testing (AST). This technique involves tracking the quantity and copy number of the highly conserved 16S rDNA gene in bacteria post-antibiotic treatment. Lee and colleagues introduced a procedure that assesses bacterial susceptibility by employing real-time PCR to monitor bacterial load through the highly conserved 16S rRNA gene. 

  • In 2023, Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) has emerged as a cutting-edge soft ionization biological mass spectrometer. This technology has transformed clinical microbiology laboratories by providing accurate microorganism identification. Its benefits of speed, precision, and ease of use have broadened its application scope, demonstrating promising potential in detecting antimicrobial resistance. MALDI-TOF MS-based AST techniques include those that identify specific resistance mechanisms as well as methods designed for universal antimicrobial susceptibility testing. 

  • Raman Spectroscopy is molecule-specific, delivering a unique molecular fingerprint. Rapid antimicrobial susceptibility testing (AST) using Raman spectroscopy can be categorized into two primary approaches: detecting the differences in characteristic spectral changes between susceptible and resistant bacteria with or without antibiotic treatment, and quantifying carbon−deuterium. To tackle this challenge, combining Raman spectroscopy with deep learning offers a novel solution for rapid AST. 

  • Recent advancements in CRISPR-Cas-mediated technologies have introduced an efficient tool for the genetic engineering of cells and organisms. 6

Antimicrobial Susceptibility Testing Key Market Trends

  • Integration of artificial intelligence (AI) and machine learning: The integration of AI and machine learning algorithms in AST data analysis is a growing trend. These technologies can assist in the interpretation of complex datasets and improve the accuracy and speed of AST results interpretation. For example, the AI-powered platform DeepAMR uses machine learning to predict bacterial susceptibility to antibiotics based on genomic data.

Antimicrobial Susceptibility Testing Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Test types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our Global Antimicrobial Susceptibility Testing (AST) Market analysis, the market is poised for significant growth in the coming years. The market analysis indicates a rising demand for AST solutions due to the increasing prevalence of antimicrobial resistance and the need for accurate and timely detection of drug-resistant pathogens. The market is driven by factors such as the growing burden of infectious diseases, the rise in hospital-acquired infections, and the need for effective treatment strategies. The adoption of rapid AST methods, the integration of molecular diagnostics, and the development of automated systems are key trends shaping the market. Despite challenges such as limited accessibility and high costs, the market presents attractive opportunities, including the demand for point-of-care testing and the focus on personalized medicine. With projections suggesting a significant market size, companies in the antimicrobial susceptibility testing market have the potential to leverage these opportunities and contribute to combating antimicrobial resistance, improving patient outcomes, and transforming infectious disease management on a global scale.

Report Metric Details
Market size value in 2023 USD 3.60 Billion
Market size value in 2031 USD 5.68 Billion
Growth Rate 5.20%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Test type
    • Phenotypic testing, genotypic testing, and rapid testing
  • End user
    • Hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies
  • Product type
    • Instruments, reagents and kits, and software and services
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Danaher Corporation (US)
  • Becton, Dickinson and Company (US)
  • bioMérieux SA (France)
  • Roche Diagnostics (Switzerland)
  • Abbott Laboratories (US)
  • Bruker Corporation (US)
  • Merck KGaA (Germany)
  • Agilent Technologies, Inc. (US)
  • ConvaTec Group plc (UK)
  • Cepheid (US)
  • HiMedia Laboratories Pvt. Ltd. (India)
  • Liofilchem s.r.l. (Italy)
  • Accelerate Diagnostics, Inc. (US)
  • Creative Diagnostics (US)
  • Bio-Rad Laboratories (US)
  • Synbiosis (UK)
  • ELITechGroup (France)
  • QIAGEN N.V. (Germany)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Antimicrobial Susceptibility Testing Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Antimicrobial Susceptibility Testing Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Antimicrobial Susceptibility Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antimicrobial Susceptibility Testing Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antimicrobial Susceptibility Testing Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Antimicrobial Susceptibility Testing Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Antimicrobial Susceptibility Testing Market size was valued at USD 3.60 Billion in 2022 and is poised to grow from USD 3.79 Billion in 2023 to USD 5.68 Billion by 2031, at a CAGR of 5.20% during the forecast period (2024-2031).

Antimicrobial Susceptibility Testing (AST) Market features a competitive landscape with several prominent players vying for market share. Key companies operating in the market are actively engaged in research and development activities to introduce advanced AST systems and technologies. Strategic collaborations, partnerships, and acquisitions are common strategies employed by these players to expand their product portfolio and strengthen their market presence. The market is characterized by intense competition, with a focus on innovation, cost-effectiveness, and accuracy of AST solutions. The presence of established players with strong distribution networks and brand recognition presents barriers to entry for new entrants. 'Thermo Fisher Scientific Inc. (US)', 'Bio-Rad Laboratories, Inc. (US)', 'Danaher Corporation (US)', 'Becton, Dickinson and Company (US)', 'bioMérieux SA (France)', 'Roche Diagnostics (Switzerland)', 'Abbott Laboratories (US)', 'Bruker Corporation (US)', 'Merck KGaA (Germany)', 'Agilent Technologies, Inc. (US)', 'ConvaTec Group plc (UK)', 'Cepheid (US)', 'HiMedia Laboratories Pvt. Ltd. (India)', 'Liofilchem s.r.l. (Italy)', 'Accelerate Diagnostics, Inc. (US)', 'Creative Diagnostics (US)', 'Bio-Rad Laboratories (US)', 'Synbiosis (UK)', 'ELITechGroup (France)', 'QIAGEN N.V. (Germany)'

The rise in antimicrobial resistance is a significant driver for the AST market. The emergence of drug-resistant pathogens poses a severe threat to public health globally. For instance, the increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections has created a dire need for accurate AST to guide clinicians in selecting appropriate antibiotics for treatment.

Integration of artificial intelligence (AI) and machine learning: The integration of AI and machine learning algorithms in AST data analysis is a growing trend. These technologies can assist in the interpretation of complex datasets and improve the accuracy and speed of AST results interpretation. For example, the AI-powered platform DeepAMR uses machine learning to predict bacterial susceptibility to antibiotics based on genomic data.

North America dominated the AST market, accounting for a substantial market share. The region's dominance can be attributed to several factors, including advanced healthcare infrastructure, well-established laboratory networks, and a strong focus on research and development activities. North America is home to prominent market players, such as bioMérieux, Thermo Fisher Scientific, and BD, which contribute to the region's market leadership. Additionally, the high prevalence of antimicrobial resistance and the proactive measures taken by healthcare organizations to address the issue drive the adoption of AST technologies in the region. With supportive government initiatives, strong investments in healthcare, and a growing emphasis on patient safety, North America holds a significant market share in the AST market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Antimicrobial Susceptibility Testing Market

Product ID: SQMIG35B2120

$5,300
BUY NOW GET FREE SAMPLE